People with metastatic melanoma on long-term immunotherapy or targeted agents

People with metastatic melanoma on long-term immunotherapy or targeted agents

Publication date: Sep 08, 2019

Julia Lai Kwon

Survivorship Conference (Day 2 – Friday 09 February 2018)

Concepts Keywords
Acute Toxicity Healthcare
Air Psychological mobility patient
Alms Immuno therapy
Bay Psychological referral systems
Cancer Questionnaire melanoma
Demographic Skin melanoma
Descriptive Statistics Fatigue
Dhe Questionnaires melanoma
DTH Brain metastases
Fatigue Prognosis metastatic melanoma
French High fear cancer
Frequency Nausea
Genesis Immunotherapy
Graph RTT
Healthcare Health
Histological Medicine
Immunotherapy Melanoma
Liberal Cancer
Malignancies Brain metastasis
Melanoma Targeted therapy
Melon Skin cancer
Morbidity Radiation therapy
Nausea Treatment of cancer
Prognosis
Questionnaire
Sonic
Statistician
Targeted Therapy
Tickling
Toxicity
Victoria

Semantics

Type Source Name
drug DRUGBANK Nonoxynol-9
disease MESH melanoma
disease DOID melanoma
pathway BSID Melanoma
gene UNIPROT ACOT11
gene UNIPROT SGSM3
disease MESH diagnosis
gene UNIPROT CASP1
gene UNIPROT CES2
disease MESH metastases
drug DRUGBANK Esomeprazole
disease MESH malignancies
gene UNIPROT SHOX2
gene UNIPROT IMPACT
gene UNIPROT MAP6
disease DOID cancer
disease MESH recurrence
disease MESH death
gene UNIPROT RXFP2
gene UNIPROT KIDINS220
disease MESH lifestyle
disease MESH community
disease MESH satisfaction
drug DRUGBANK Medical air
disease MESH uncertainty
disease MESH development
drug DRUGBANK Ranitidine
gene UNIPROT RAN

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *